THR-beta agonist 2 is a potent agonist of THR-beta. THR-beta agonist 2 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021121210A1, compound 3)[1].
Molekulargewicht:
443.20
Reinheit:
99.31
CAS Nummer:
[2440027-77-8]
Formel:
C18H8Cl2N6O4
Target-Kategorie:
Thyroid Hormone Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten